101 - 110 of 6230 Results
Title
Year
- Activation of the mGlu1 metabotropic glutamate receptor has antipsychotic-like effects and is required for efficacy of M4 muscarinic receptor allosteric modulators2018OPENTitle: Activation of the mGlu1 metabotropic glutamate receptor has antipsychotic-like effects and is required for efficacy of M4 muscarinic receptor allosteric modulatorsJournal Name: Molecular PsychiatryPublisher: Springer Science and Business Media LLCVol: 25Issue #: 11Start Page: 2786End Page: 2799Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41380-018-0206-2Best OA location URL: https://www.nature.com/articles/s41380-018-0206-2.pdfCitation Count: 46
-
OPENTitle: Alzheimer Research Forum Live Discussion: Mice on Trial? Issues in the Design of Drug StudiesJournal Name: Journal of Alzheimer's DiseasePublisher: SAGE PublicationsVol: 16Issue #: 1Start Page: 197End Page: 205Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jad-2009-0961Best OA location URL: https://content.iospress.com:443/download/journal-of-alzheimers-disease/jad00961?id=journal-of-alzheimers-disease%2Fjad00961Citation Count: 1
-
OPENTitle: The Impact of COVID‐19 on Access to Parkinson's Disease MedicationJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 12Start Page: 2129End Page: 2133Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28293Best OA location URL: https://onlinelibrary.wiley.com/doi/pdf/10.1002/mds.28293Citation Count: 44
- Mitochondrial Function in Hereditary Spastic Paraplegia: Deficits in SPG7 but Not SPAST Patient-Derived Stem Cells2020OPENTitle: Mitochondrial Function in Hereditary Spastic Paraplegia: Deficits in SPG7 but Not SPAST Patient-Derived Stem CellsJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2020.00820Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2020.00820/pdfCitation Count: 25
-
OPENTitle: Advances in Therapeutic Options for Gait and Balance in Parkinson’s DiseaseJournal Name: US NeurologyPublisher: Touch Medical Media, Ltd.Vol: 07Issue #: 02Start Page: 100End Page: 100Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.17925/usn.2011.07.02.100Best OA location URL: http://www.touchneurology.com/wp-content/uploads/sites/3/2015/07/private_articles_10210_pdf_chou.pdfCitation Count: 20
-
OPENTitle: Cerebral blood flow in Alzheimer’s diseaseJournal Name: Vascular Health and Risk ManagementPublisher: Informa UK LimitedVol:Issue #:Start Page: 599End Page: 599Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.2147/vhrm.s34874Best OA location URL: https://www.dovepress.com/getfile.php?fileID=14292Citation Count: 187
-
OPENTitle: Neuroprotective activities of regulatory T cellsJournal Name: Trends in Molecular MedicinePublisher: Elsevier BVVol: 17Issue #: 12Start Page: 687End Page: 688Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.molmed.2011.08.005Best OA location URL: http://doi.org/10.1016/j.molmed.2011.08.005Citation Count: 51
- Recruitment of patients with de novo Parkinson disease: successful strategies in a randomized exercise clinical trial2018OPENTitle: Recruitment of patients with de novo Parkinson disease: successful strategies in a randomized exercise clinical trialJournal Name: TrialsPublisher: Springer Science and Business Media LLCVol: 19Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13063-018-2958-zBest OA location URL: https://trialsjournal.biomedcentral.com/track/pdf/10.1186/s13063-018-2958-zCitation Count: 11
- Lentiviral Overexpression of GRK6 Alleviates l -Dopa–Induced Dyskinesia in Experimental Parkinson’s Disease2010OPENTitle: Lentiviral Overexpression of GRK6 Alleviates l -Dopa–Induced Dyskinesia in Experimental Parkinson’s DiseaseJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 2Issue #: 28Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.3000664Best OA location URL: http://doi.org/10.1126/scitranslmed.3000664Citation Count: 135
- Pharmacological Rescue of Mitochondrial Deficits in iPSC-Derived Neural Cells from Patients with Familial Parkinson’s Disease2012OPENTitle: Pharmacological Rescue of Mitochondrial Deficits in iPSC-Derived Neural Cells from Patients with Familial Parkinson’s DiseaseJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 4Issue #: 141Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.3003985Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3462009Citation Count: 490